NCT06519097 2025-11-13
Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT04207944 2025-06-15
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
Duke University
Phase 2 Active not recruiting
NCT00482625 2014-10-16
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Terminated